approval
savePRALUENT (ALIROCUMAB) — FDA approval
community read0 votes
Sponsor: REGENERON PHARMACEUTICALS. Form: INJECTABLE. Route: INJECTION
view source ↗Data sources
last refreshed 5mo ago
Found something off?
drug timeline · 8
- approvalPRALUENT (ALIROCUMAB) — FDA approvalOct 9, 2025 · 366d ago
- approvalPRALUENT (ALIROCUMAB) — FDA approvalMar 8, 2024 · 946d ago
- approvalPRALUENT (ALIROCUMAB) — FDA approvalApr 1, 2021 · 2018d ago
- approvalPRALUENT (ALIROCUMAB) — FDA approvalApr 1, 2021 · 2018d ago
- approvalPRALUENT (ALIROCUMAB) — FDA approvalApr 26, 2019 · 2724d ago
- approvalPRALUENT (ALIROCUMAB) — FDA approvalApr 26, 2019 · 2724d ago
- approvalPRALUENT (ALIROCUMAB) — FDA approvalNov 6, 2018 · 2895d ago
- approvalPRALUENT (ALIROCUMAB) — FDA approvalAug 22, 2018 · 2971d ago
comments(0)
5-min edit window · permanent after that